The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Role of Gastrointestinal Hormones in Postprandial Reduction of Bone Resorption
Open accessAbstract
Collagen type I fragments, reflecting bone resorption, and release of gut hormones were investigated after a meal. Investigations led to a dose escalation study with glucagon like peptide-2 (GLP-2) in postmenopausal women. We found a dose-dependent effect of GLP-2 on the reduction of bone resorption. Introduction: The C-terminal telopeptide region of type I collagen as measured in serum (s-CTX) can be used to assess bone resorption. This marker of bone resorption has a significant circadian variation that is influenced by food intake. However, the mediator of this variation has not been identified. Materials and Methods: We studied the release of the gut hormones glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-2 (GLP-2; a representative of the intestinal proglucagon-derived peptides) after ingestion of glucose, fat, protein, and fructose, as well as their effects after parenteral administration in relation to bone turnover processes in healthy volunteers. Furthermore, we studied the effect on bone turnover of a single subcutaneous injection of GLP-2 in four different dosages (100, 200, 400, or 800 μg GLP-2) or placebo in 60 postmenopausal women (mean age, 61 ± 5 years). Results: All macronutrients significantly (p < 0.05) reduced bone resorption as assessed by s-CTX (39–52% from baseline), and only the glucagon-like peptides were secreted in parallel. Parenteral administration of GIP and GLP-1 did not result in a reduction of the s-CTX level, whereas GLP-2 caused a statistically significant and dose-dependent reduction in the s-CTX level from baseline compared with placebo (p < 0.05). Urine DPD/creatinine, a marker of bone resorption, was significantly reduced by 25% from baseline in the 800-μg GLP-2 group (p < 0.01). An area under the curve (AUC0–8h) analysis for s-CTX after GLP-2 injection confirmed the dose-dependent decrease (ANOVA, p = 0.05). The s-osteocalcin level was unaffected by the GLP-2 treatment. Conclusion: These studies exclude both GIP and GLP-1 as key mediators for the immediate reduction in bone resorption seen after a meal. The dose-dependent reduction of bone resorption markers found after subcutaneous injection of GLP-2 warrants further investigation into the mechanism and importance of GLP-2 for the bone turnover processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Manolagas, S. C. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0395 · Cited by 2,568
Kieffer, T. J., & Francis Habener, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0385 · Cited by 1,062
Parfitt, A. M. (1994) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240550303 · Cited by 1,001 · cited 1×
“adult life, osteoblastic bone formation and osteoclastic resorption are thought to be closely coordinated.((1,2)) Further-”
BackgroundTissue and Plasma Concentrations of Amidated and Glycine-Extended Glucagon-Like Peptide I in Humans
Ørskov, C., Rabenhøj, L., Wettergren, A., Kofod, H., & Holst, J. J. (1994) · Diabetes · doi:10.2337/diab.43.4.535 · Cited by 919
Self-citationVilsbøll, T., Krarup, T., Deacon, C. F., Madsbad, S., & Holst, J. J. (2001) · Diabetes · doi:10.2337/diabetes.50.3.609 · Cited by 884
Self-citationInduction of intestinal epithelial proliferation by glucagon-like peptide 2.
Drucker, D. J., Erlich, P., Asa, S. L., & Brubaker, P. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.7911 · Cited by 880
Elliott, R. M., Morgan, L. M., Tredger, J. A., Deacon, S., Wright, J., & Marks, V. (1993) · Journal of Endocrinology · doi:10.1677/joe.0.1380159 · Cited by 695
Jeppesen, P. B., Hartmann, B., Thulesen, J., Graff, J., Lohmann, J., Hansen, B. S., Tofteng, F., Poulsen, S. S., Madsen, J. L., Holst, J. J., et al. (2001) · Gastroenterology · doi:10.1053/gast.2001.22555 · Cited by 532
Self-citationFEHMANN, H.-C., GÖKE, R., & GÖKE, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-390 · Cited by 528
T., V., T., K., S., M., & J., H. (2002) · Diabetologia · doi:10.1007/s00125-002-0878-6 · Cited by 518
Origin of the vitamin K-dependent bone protein found in plasma and its clearance by kidney and bone.
Price, P. A., Williamson, M. K., & Lothringer, J. W. (1981) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42960-2 · Cited by 485
Parfitt, A. M. (2002) · Bone · doi:10.1016/s8756-3282(01)00642-1 · Cited by 462
Qvist, P., Christgau, S., Pedersen, B. J., Schlemmer, A., & Christiansen, C. (2002) · Bone · doi:10.1016/s8756-3282(02)00791-3 · Cited by 348
Self-citationModulation of specific intestinal epithelial progenitors by enteric neurons
Bjerknes, M., & Cheng, H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211278098 · Cited by 325
Rosenquist, C., Fledelius, C., Christgau, S., Pedersen, B. J., Bonde, M., Qvist, P., & Christiansen, C. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.11.2281 · Cited by 318
Self-citationEffect of feeding on bone turnover markers and its impact on biological variability of measurements
Clowes, J. A., Hannon, R. A., Yap, T. S., Hoyle, N. R., Blumsohn, A., & Eastell, R. (2002) · Bone · doi:10.1016/s8756-3282(02)00728-7 · Cited by 296
Tang-Christensen, M., Larsen, P. J., Thulesen, J., Rømer, J., & Vrang, N. (2000) · Nature Medicine · doi:10.1038/77535 · Cited by 269
Holst, J. J. (1997) · Annual Review of Physiology · doi:10.1146/annurev.physiol.59.1.257 · Cited by 267
Self-citationMechanism of circadian variation in bone resorption
Bjarnason, N. H., Henriksen, E. E. G., Alexandersen, P., Christgau, S., Henriksen, D. B., & Christiansen, C. (2002) · Bone · doi:10.1016/s8756-3282(01)00662-7 · Cited by 262
Self-citationGastric Inhibitory Polypeptide: the neglected incretin revisited
Meier, J. J., Nauck, M. A., Schmidt, W. E., & Gallwitz, B. (2002) · Regulatory Peptides · doi:10.1016/s0167-0115(02)00039-3 · Cited by 226
Structure, measurement, and secretion of human glucagon-like peptide-2
Hartmann, B., Johnsen, A. H., Ørskov, C., Adelhorst, K., Thim, L., & Holst, J. J. (2000) · Peptides · doi:10.1016/s0196-9781(99)00176-x · Cited by 221
Self-citationXiao, Q., Boushey, R. P., Drucker, D. J., & Brubaker, P. L. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70555-x · Cited by 210
Glucagon-Like Peptide-2 Inhibits Centrally Induced Antral Motility in Pigs
M. WØJDEMANN, A. W. (1998) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365529850171486 · Cited by 210
Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy
Christgau, S., Bitsch-Jensen, O., Hanover Bjarnason, N., Gamwell Henriksen, E., Qvist, P., Alexandersen, P., & Bang Henriksen, D. (2000) · Bone · doi:10.1016/s8756-3282(00)00248-9 · Cited by 200
Self-citationMeasurement of a more stable region of osteocalcin in serum by ELISA with two monoclonal antibodies
Rosenquist, C., Qvist, P., Bjarnason, N., & Christiansen, C. (1995) · Clinical Chemistry · doi:10.1093/clinchem/41.10.1439 · Cited by 177
Self-citationInhibition of Sham Feeding-Stimulated Human Gastric Acid Secretion by Glucagon-Like Peptide-2
Wøjdemann, M., Wettergren, A., Hartmann, B., Hilsted, L., & Holst, J. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.7.5840 · Cited by 167
Self-citationRole of parathyroid hormone in mediating nocturnal and age-related increases in bone resorption
Ledger, G. A., Burritt, M. F., Kao, P.-C., O’Fallon, W. M., Riggs, B. L., & Khosla, S. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.11.7593443 · Cited by 152
Holst, J. J. (1999) · Trends in Endocrinology and Metabolism · doi:10.1016/s1043-2760(99)00157-5 · Cited by 146
Self-citationAcute fasting diminishes the circadian rhythm of biochemical markers of bone resorption
Schlemmer, A., & Hassager, C. (1999) · European Journal of Endocrinology · doi:10.1530/eje.0.1400332 · Cited by 138
Hartmann, B., Thulesen, J., Kissow, H., Thulesen, S., Ørskov, C., Röpke, C., Poulsen, S. S., & Holst, J. J. (2000) · Endocrinology · doi:10.1210/endo.141.11.7752 · Cited by 134
Self-citationCaillot-Augusseau, A., Vico, L., Heer, M., Voroviev, D., Souberbielle, J.-C., Zitterman, A., Alexandre, C., & Lafage-Proust, M.-H. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.8.1136 · Cited by 133 · cited 1×
“Moreover, it has been shown that skeletal unloading obtained through a 5-day bed rest or weightlessness during space flight does not alter the circadian variation of bone resorption.((8,9)) Several hormones, including parathyroid hormone (PTH) and cortisol, also exhibit circadian rhythms and thus could be candidates f…”
BackgroundAppetite regulation by carbohydrate: role of blood glucose and gastrointestinal hormones
Lavin, J., Wittert, G., Sun, W. M., Horowitz, M., Morley, J. E., & Read, N. W. (1996) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1996.271.2.e209 · Cited by 112
Krarup, T., & Holst, J. J. (1984) · Regulatory Peptides · doi:10.1016/0167-0115(84)90005-3 · Cited by 109
Self-citationSykes, S. D., Morgan, L., ENGLISH, J., & Marks, V. (1980) · Journal of Endocrinology · doi:10.1677/joe.0.0850201 · Cited by 109
Drucker, D. J. (2001) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.86.4.7386 · Cited by 107
Diurnal Rhythm of CrossLaps in Human Serum
Wichers, M., Schmidt, E., BIDLINGMAIER, F., & Klingmüller, D. (1999) · Clinical Chemistry · doi:10.1093/clinchem/45.10.1858 · Cited by 105
Effects of oral fructose and glucose on plasma GLP-1 and appetite in normal subjects
Kong, M., Chapman, I. M., Goble, E., Wishart, J. M., Wittert, G., Morris, H. A., & Horowitz, M. (1999) · Peptides · doi:10.1016/s0196-9781(99)00006-6 · Cited by 102
Haderslev, K. V., Jeppesen, P. B., Hartmann, B., Thulesen, J., Sørensen, H. A., Graff, J., Hansen, B. S., Tofteng, F., Poulsen, S. S., Madsen, J. L., et al. (2002) · Scandinavian Journal of Gastroenterology · doi:10.1080/003655202317316006 · Cited by 96
Self-citationHeshmati, H. M., Riggs, B. L., Burritt, M. F., McAlister, C. A., Wollan, P. C., & Khosla, S. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.3.4627 · Cited by 93
Clowes, J. A., Robinson, R. T. C. E., Heller, S. R., Eastell, R., & Blumsohn, A. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.7.8660 · Cited by 92
Schlemmer, A., Hassager, C., Pedersen, B. J., & Christiansen, C. (1994) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650091207 · Cited by 78
Self-citationVilsbøll, T., Krarup, T., Madsbad, S., & Holst, J. J. (2001) · Diabetic Medicine · doi:10.1046/j.1464-5491.2001.00424.x · Cited by 72
Self-citationNIELSEN, H. K., Laurberg, P., Brixen, K., & Mosekilde, L. (1991) · European Journal of Endocrinology · doi:10.1530/acta.0.1240391 · Cited by 71
Gut hormones as pharmaceuticals
Holst, J. J. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00185-3 · Cited by 65
Self-citationAssays for Peptide Products of Somatostatin Gene Expression
Holst, J. J., & Bersani, M. (1991) · Methods in neurosciences · doi:10.1016/b978-0-12-185259-7.50006-5 · Cited by 63
Self-citationNew frontiers in the biology of GLP-2
Lovshin, J. A., & Drucker, D. J. (2000) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00117-8 · Cited by 62
Metabolic Effects of Glucose, Mannose, Galactose, and Fructose in Man*
Ganda, O. P., Soeldner, J. S., Gleason, R. E., Cleator, I. G. M., & REYNOLDS, C. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-49-4-616 · Cited by 56
Vozzo, R., Baker, B., Wittert, G., Wishart, J. M., Morris, H. A., Horowitz, M., & Chapman, I. (2002) · Metabolism · doi:10.1053/meta.2002.34012 · Cited by 38
Circadian rhythm of in vitro bone-resorbing activity in human serum
Lakatos, P. L., Blumsohn, A., Eastell, R., Tarján, G., Shinoda, H., & Stern, P. H. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.11.3185 · Cited by 36
Determinants of gastric inhibitory polypeptide and insulin secretion
Williams, R. H., May, J. M., & Biesbroeck, J. B. (1981) · Metabolism · doi:10.1016/0026-0495(81)90215-8 · Cited by 16
Cited by
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639
The Physiology of Glucagon-like Peptide 1
Holst, J. J. (2007) · Physiological Reviews · doi:10.1152/physrev.00034.2006 · Cited by 3,371
Self-citationOsteoporosis: now and the future
Rachner, T. D., Khosla, S., & Hofbauer, L. C. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62349-5 · Cited by 2,696
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
“In contrast to GLP-2 administration, subcutaneous injection of GLP-1 in healthy individuals had no effects on bone formation or resorption markers [869].”
BackgroundSelf-citationPharmacology, physiology, and mechanisms of incretin hormone action.
Campbell, J. E., & Drucker, D. J. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.04.008 · Cited by 1,500
Metadata
- Authors
- Henriksen, D. B., Alexandersen, P., Bjarnason, N. H., Vilsbøll, T., Hartmann, B., Henriksen, E. E., Byrjalsen, I., Krarup, T., Holst, J. J., & Christiansen, C.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-12-01
- Volume
- 18
- Issue
- 12
- Pages
- 2180-2189
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2091403268
- Cited by
- 332
- References
- 50
- FWCI
- 7.45
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.